PubMed

Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis.

Ortegon MM, Redekop WK, Niessen LW.

Diabetes Care. 2004 Apr;27(4):901-7.PMID: 15047646 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines.

van Os N, Niessen LW, Bilo HJ, Casparie AF, van Hout BA.

Health Policy. 2000 Apr;51(3):135-47.PMID: 10720684 [PubMed - indexed for MEDLINE]Related articles

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.PMID: 17999840 [PubMed - indexed for MEDLINE]Related articlesFree article

Management and prevention of diabetic foot ulcers and infections: a health economic review.

Chow I, Lemos EV, Einarson TR.

Pharmacoeconomics. 2008;26(12):1019-35. doi: 10.2165/0019053-200826120-00005. Review.PMID: 19014203 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.

CDC Diabetes Cost-effectiveness Group.

JAMA. 2002 May 15;287(19):2542-51.PMID: 12020335 [PubMed - indexed for MEDLINE]Related articlesFree article

An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers.

Dougherty EJ.

Adv Skin Wound Care. 2008 Dec;21(12):568-75.PMID: 19065083 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.

Dong FB, Sorensen SW, Manninen DL, Thompson TJ, Narayan V, Orians CE, Gregg EW, Eastman RC, Dasbach EJ, Herman WH, Newman JM, Narva AS, Ballard DJ, Engelgau MM.

Pharmacoeconomics. 2004;22(15):1015-27.PMID: 15449965 [PubMed - indexed for MEDLINE]Related articles

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

Model-based evaluation of diabetic foot prevention strategies in Austria.

Rauner MS, Heidenberger K, Pesendorfer EM.

Health Care Manag Sci. 2005 Nov;8(4):253-65. Review.PMID: 16379409 [PubMed - indexed for MEDLINE]Related articles

Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations.

Ragnarson Tennvall G, Apelqvist J.

Diabetologia. 2001 Nov;44(11):2077-87.PMID: 11719840 [PubMed - indexed for MEDLINE]Related articles

Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.

Spencer M, Briggs AH, Grossman RF, Rance L.

Pharmacoeconomics. 2005;23(6):619-37.PMID: 15960557 [PubMed - indexed for MEDLINE]Related articles

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.PMID: 16904046 [PubMed - indexed for MEDLINE]Related articlesFree article

A model to analyse costs and benefit of intensified diabetic foot care in Austria.

Habacher W, Rakovac I, Görzer E, Haas W, Gfrerer RJ, Wach P, Pieber TR.

J Eval Clin Pract. 2007 Dec;13(6):906-12.PMID: 18070261 [PubMed - indexed for MEDLINE]Related articles

Visual screening for malignant melanoma: a cost-effectiveness analysis.

Losina E, Walensky RP, Geller A, Beddingfield FC 3rd, Wolf LL, Gilchrest BA, Freedberg KA.

Arch Dermatol. 2007 Jan;143(1):21-8.PMID: 17224538 [PubMed - indexed for MEDLINE]Related articlesFree article

Patient-centred and professional-directed implementation strategies for diabetes guidelines: a cluster-randomized trial-based cost-effectiveness analysis.

Dijkstra RF, Niessen LW, Braspenning JC, Adang E, Grol RT.

Diabet Med. 2006 Feb;23(2):164-70.PMID: 16433714 [PubMed - indexed for MEDLINE]Related articles

An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands.

Boersma C, Carides GW, Atthobari J, Voors AA, Postma MJ.

Clin Ther. 2007 May;29(5):963-71.PMID: 17697915 [PubMed - indexed for MEDLINE]Related articles

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.PMID: 17999842 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost effectiveness of Apligraf treatment of diabetic foot ulcers.

Redekop WK, McDonnell J, Verboom P, Lovas K, Kalo Z.

Pharmacoeconomics. 2003;21(16):1171-83.PMID: 14594438 [PubMed - indexed for MEDLINE]Related articles

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.PMID: 16545207 [PubMed - indexed for MEDLINE]Related articlesFree article

A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.

Gupta OP, Brown GC, Brown MM.

Am J Ophthalmol. 2008 May;145(5):923-8. Epub 2008 Mar 10.PMID: 18329000 [PubMed - indexed for MEDLINE]Related articles